Price Jennifer C. Purchases Shares of 96,000 Solventum Co. (NYSE:SOLV)

Price Jennifer C. purchased a new position in shares of Solventum Co. (NYSE:SOLV) in the 2nd quarter, Holdings Channel.com reports. The fund purchased 96,000 shares of the company’s stock, valued at approximately $5,076,000. Solventum comprises about 5.9% of Price Jennifer C.’s portfolio, making the stock its 5th largest position.

Other large investors also recently modified their holdings of the company. Fifth Lane Capital LP purchased a new position in shares of Solventum in the 1st quarter valued at $826,000. Boit C F David purchased a new position in Solventum in the first quarter valued at about $152,000. Mitsubishi UFJ Trust & Banking Corp purchased a new position in Solventum in the first quarter valued at about $5,747,000. GABELLI & Co INVESTMENT ADVISERS INC. acquired a new position in shares of Solventum during the first quarter worth about $209,000. Finally, LRI Investments LLC acquired a new stake in shares of Solventum in the first quarter valued at about $43,000.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on SOLV shares. Wolfe Research began coverage on Solventum in a research report on Thursday. They set a “peer perform” rating on the stock. Argus began coverage on shares of Solventum in a research report on Monday, June 24th. They set a “hold” rating on the stock. BTIG Research started coverage on shares of Solventum in a research note on Thursday, September 5th. They issued a “neutral” rating for the company. Morgan Stanley dropped their price target on shares of Solventum from $70.00 to $55.00 and set an “equal weight” rating on the stock in a research note on Monday, July 15th. Finally, Wells Fargo & Company decreased their price objective on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a research report on Friday, August 9th. One investment analyst has rated the stock with a sell rating and seven have assigned a hold rating to the stock. Based on data from MarketBeat, Solventum has a consensus rating of “Hold” and an average price target of $58.25.

Solventum Trading Down 0.8 %

Solventum stock opened at $67.57 on Monday. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.31 and a quick ratio of 0.96. The firm’s 50 day simple moving average is $62.70.

Solventum (NYSE:SOLV) last posted its quarterly earnings data on Thursday, August 8th. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.10. The company had revenue of $2.08 billion for the quarter, compared to the consensus estimate of $2.05 billion. The company’s revenue for the quarter was up .2% on a year-over-year basis. On average, analysts forecast that Solventum Co. will post 6.38 earnings per share for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.